Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-01-18 10:32 am Sale |
2023-12-31 | 13G | ShotSpotter, Inc. SSTI |
FEDERATED HERMES INC. FHI |
1,315,000 10.340% |
-5,594![]() (-0.42%) |
Filing History |
2024-01-18 10:31 am Purchase |
2023-12-31 | 13G | SCYNEXIS, Inc. SCYX |
FEDERATED HERMES INC. FHI |
8,094,700 19.990% |
1,227,786![]() (+17.88%) |
Filing History |
2024-01-18 10:29 am Purchase |
2023-12-31 | 13G | Rezolute, Inc. RZLT |
FEDERATED HERMES INC. FHI |
8,250,274 19.990% |
700,000![]() (+9.27%) |
Filing History |
2024-01-18 10:25 am Purchase |
2023-12-31 | 13G | Regulus Therapeutics Inc. RGLS |
FEDERATED HERMES INC. FHI |
4,023,860 19.900% |
148,282![]() (+3.83%) |
Filing History |
2024-01-18 10:23 am Unchanged |
2023-12-31 | 13G | P10, Inc. PX |
FEDERATED HERMES INC. FHI |
3,181,933 5.990% |
0 (Unchanged) |
Filing History |
2024-01-18 10:21 am Purchase |
2023-12-31 | 13G | Minerva Neurosciences, Inc. NERV |
FEDERATED HERMES INC. FHI |
1,351,275 19.320% |
150,000![]() (+12.49%) |
Filing History |
2024-01-18 10:19 am Purchase |
2023-12-31 | 13G | Merus N.V. MRUS |
FEDERATED HERMES INC. FHI |
3,637,309 6.300% |
1,498,609![]() (+70.07%) |
Filing History |
2024-01-18 10:17 am Purchase |
2023-12-31 | 13G | aTyr Pharma, Inc. ATYR |
FEDERATED HERMES INC. FHI |
10,169,600 17.370% |
4,938,000![]() (+94.39%) |
Filing History |
2024-01-18 10:15 am Purchase |
2023-12-31 | 13G | IDEAYA Biosciences, Inc. IDYA |
FEDERATED HERMES INC. FHI |
3,883,775 6.030% |
1,019,275![]() (+35.58%) |
Filing History |
2024-01-18 10:11 am Purchase |
2023-12-31 | 13G | Fusion Pharmaceuticals Inc. FUSN |
FEDERATED HERMES INC. FHI |
10,886,153 15.030% |
252,364![]() (+2.37%) |
Filing History |
2024-01-18 10:10 am Sale |
2023-12-31 | 13G | Dynavax Technologies Corporation DVAX |
FEDERATED HERMES INC. FHI |
11,364,666 8.790% |
-1,275,697![]() (-10.09%) |
Filing History |
2024-01-17 2:43 pm Purchase |
2023-12-31 | 13G | Arcturus Therapeutics Holdings Inc. ARCT |
FEDERATED HERMES INC. FHI |
4,711,512 17.630% |
471,958![]() (+11.13%) |
Filing History |
2024-01-17 2:36 pm Sale |
2023-12-31 | 13G | Amphastar Pharmaceuticals, Inc. AMPH |
FEDERATED HERMES INC. FHI |
3,272,761 6.830% |
-11,456![]() (-0.35%) |
Filing History |
2023-12-08 4:16 pm Purchase |
2023-11-30 | 13G | Federated Hermes, Inc. FHI |
The Vanguard Group | 8,713,532 10.100% |
229,705![]() (+2.71%) |
Filing History |
2023-11-07 12:57 pm Sale |
2023-10-31 | 13G | Seres Therapeutics, Inc. MCRB |
FEDERATED HERMES INC. FHI |
5,175,805 4.040% |
-6,324,715![]() (-55.00%) |
Filing History |
2023-09-07 10:14 am Sale |
2023-08-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM |
FEDERATED HERMES INC. FHI |
2,341,335 4.110% |
-3,963,147![]() (-62.86%) |
Filing History |
2023-08-08 08:36 am Sale |
2023-07-31 | 13G | Annexon, Inc. ANNX |
FEDERATED HERMES INC. FHI |
2,342,715 4.410% |
-715,085![]() (-23.39%) |
Filing History |
2023-07-07 4:35 pm Sale |
2023-06-30 | 13G | Federated Hermes, Inc. FHI |
BLACKROCK INC BLK |
7,913,438 8.800% |
-4,412,580![]() (-35.80%) |
Filing History |
2023-06-09 08:35 am Sale |
2023-05-31 | 13G | MALLINCKRODT PLC SHS MNKTQ |
FEDERATED HERMES INC. FHI |
515,988 3.920% |
-482,970![]() (-48.35%) |
Filing History |
2023-06-09 08:19 am Purchase |
2023-05-31 | 13G | Fusion Pharmaceuticals Inc. FUSN |
FEDERATED HERMES INC. FHI |
10,633,789 16.660% |
7,409,689![]() (+229.82%) |
Filing History |